Skip to main content

Sherman Mark Andrew's Form 4 filing

Dolby Laboratories, Inc. (DLB) · filed May 10, 2023

Accession no.
0001209191-23-028505
Filed
May 10, 2023
Trade date
May 8, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.25M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sherman Mark AndrewCIK 0001256708Officer (EVP, Gen. Counsel & Secretary)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 8, 2023Class A Common StockMOption exerciseAcquired+11,118$45.50+$505,86967,492Direct
May 8, 2023Class A Common StockMOption exerciseAcquired+3,882$62.32+$241,926.2471,374Direct
May 8, 2023Class A Common StockSSaleDisposed−12,820$83.47F2−$1,070,085.458,554Direct
May 8, 2023Class A Common StockSSaleDisposed−2,180$84.35F3−$183,88356,374Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 8, 2023Class A Common StockMOption exerciseDisposed−11,118$0.00$00Direct
May 8, 2023Class A Common StockMOption exerciseDisposed−3,882$0.00$022,998Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The shares were sold in multiple transactions at prices ranging from $83.07 to $84.015, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Referenced by the price of 1 transaction in Table I.

F3

The shares were sold in multiple transactions at prices ranging from $84.10 to $84.735, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Referenced by the price of 1 transaction in Table I.

Remarks

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 22, 2023 which was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) in effect at the time of adoption.

Read the full filing on SEC EDGAR (opens in a new tab)